Model DetailsMammary gland adenocarcinoma
Model Name |
Mammary gland adenocarcinoma | Strain |
CD-1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
mammary adenocarcinoma • mammary neoplasm • mammary carcinoma • mammary gland adenocarcinoma • mammary tumor • mammary gland, adenocarcinoma • reproductive tract tumor |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Mammary gland | Male |
0% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Mammary gland | Male |
0% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Mammary gland | Female |
4.7% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Mammary gland | Female |
4.6% |
|
Baldrick P, Toxicol Pathol 2007;35(4):562-9 | |
| Mammary gland | Male |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Mammary gland | Female |
2.5% (18 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Liver | Female |
0.1% (1 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Lung | Female |
0.8% (6 of 725 mice) |
|
Chandra M, Toxicol Lett 1992 Jun;61(1):67-74 | |
| Mammary gland | Male |
0% (0 of 891 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Mammary gland | Female |
6.3% (56 of 890 mice) |
up to 109 weeks |
|
Maita K, Toxicol Pathol 1988;16(3):340-9 |
| Mammary gland | Female |
observed |
|
McLachlan JA, Cancer Res 1980 Nov;40(11):3988-99 | |
| Mammary gland | Female |
0% (0 of 31 mice) |
1 year |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Mammary gland | Female |
0% (0 of 23 mice) |
2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Mammary gland | Female |
0% (0 of 54 mice) |
1-2 years |
|
Diwan BA, Toxicol Appl Pharmacol 1999 Nov 15;161(1):82-99 |
| Mammary gland | Female |
observed |
≥1 year |
|
Brayton CF, Vet Pathol 2012 Jan;49(1):85-105 |
| Mammary gland | Female |
0% (0 of 1453 mice) |
up to 39 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Mammary gland | Female |
0.14% (2 of 1453 mice) |
up to 40 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |
| Mammary gland | Female |
0.14% (2 of 1453 mice) |
up to 50 weeks |
|
Son WC, Toxicol Lett 2003 Nov 1;145(1):88-98 |